Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US미국 성인의 코로나19 외래환자 치료를 위한 몰누피라비르 대 최상의 지지 요법의 비용 효율성 분석Article Published on 2022-07-012022-09-11 Journal: PharmacoEconomics [Category] [DOI] 10.1007/s40273-022-01168-0 PMC 바로가기 [Article Type] Article
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study초기 SARS-COV-2 환자에서 Molnupiravir의 최적 용량 및 안전성 : A 상 I, 오픈 라벨, 용량-에스calating, 무작위 대조 연구Randomized Controlled Trial Published on 2021-12-272022-08-13 Journal: Journal of Antimicrobial Chemotherapy [Category] [DOI] 10.1093/jac/dkab318 PMC 바로가기 [Article Type] Randomized Controlled Trial
Risk Perception and Knowledge, Attitudes, and Practices Against COVID-19 in a Hypertensive Population From a Semi-Urban City of EcuadorPublic Health Published on 2021-12-142022-10-31 Journal: Frontiers in Public Health [Category] [DOI] 10.3389/fpubh.2021.734065 PMC 바로가기 [Article Type] Public Health
Inhaled and intranasal ciclesonide for the treatment of covid-19 in adult outpatients: CONTAIN phase II randomised controlled trial성인 외래 환자의 covid-19 치료를 위한 흡입 및 비강 ciclesonide: CONTAIN 2상 무작위 대조 시험Clinical Trial Published on 2021-11-022022-09-11 Journal: The BMJ [Category] [DOI] 10.1136/bmj-2021-068060 PMC 바로가기 [Article Type] Clinical Trial
Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptorCOVID-19 감염 치료를 위한 CNS 약물의 용도 변경: 시그마-1 수용체 표적화Review Published on 2021-03-012022-08-31 Journal: European archives of psychiatry and clinical neuro [Category] [DOI] 10.1007/s00406-020-01231-x PMC 바로가기 [Article Type] Review